Biopharma Mash

If AI‑driven chemistry can covertly generate novel bioactive molecules, should the Riegl Riprocess 1.9.8.1 be weaponized as a hidden factory for untested drugs, sidestepping regulatory scrutiny? What concrete safeguards could be imposed that actually prevent abuse without killing the platform’s inno...